These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28360027)

  • 1. Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE).
    REPOSE Study Group
    BMJ; 2017 Mar; 356():j1285. PubMed ID: 28360027
    [No Abstract]   [Full Text] [Related]  

  • 2. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial.
    Pollard DJ; Brennan A; Dixon S; Waugh N; Elliott J; Heller S; Lee E; Campbell M; Basarir H; White D;
    BMJ Open; 2018 Apr; 8(4):e016766. PubMed ID: 29627802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trial.
    White D; Waugh N; Elliott J; Lawton J; Barnard K; Campbell MJ; Dixon S; Heller S;
    BMJ Open; 2014 Sep; 4(9):e006204. PubMed ID: 25186159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial.
    Reznik Y; Cohen O; Aronson R; Conget I; Runzis S; Castaneda J; Lee SW;
    Lancet; 2014 Oct; 384(9950):1265-72. PubMed ID: 24998009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial.
    DAFNE Study Group
    BMJ; 2002 Oct; 325(7367):746. PubMed ID: 12364302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for a cluster randomised controlled trial of the DAFNE
    Coates E; Amiel S; Baird W; Benaissa M; Brennan A; Campbell MJ; Chadwick P; Chater T; Choudhary P; Cooke D; Cooper C; Cross E; De Zoysa N; Eissa M; Elliott J; Gianfrancesco C; Good T; Hopkins D; Hui Z; Lawton J; Lorencatto F; Michie S; Pollard DJ; Rankin D; Schutter J; Scott E; Speight J; Stanton-Fay S; Taylor C; Thompson G; Totton N; Yardley L; Zaitcev A; Heller S;
    BMJ Open; 2021 Jan; 11(1):e040438. PubMed ID: 33462097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
    Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
    Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the Flexible Lifestyles Empowering Change intervention on metabolic and psychosocial outcomes in adolescents with type 1 diabetes (FLEX): a randomised controlled trial.
    Mayer-Davis EJ; Maahs DM; Seid M; Crandell J; Bishop FK; Driscoll KA; Hunter CM; Kichler JC; Standiford D; Thomas JM;
    Lancet Child Adolesc Health; 2018 Sep; 2(9):635-646. PubMed ID: 30119757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population.
    Bratke H; Margeirsdottir HD; Assmus J; Njølstad PR; Skrivarhaug T
    Diabetes Ther; 2021 Sep; 12(9):2571-2583. PubMed ID: 34389930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial.
    Furler J; O'Neal D; Speight J; Manski-Nankervis JA; Gorelik A; Holmes-Truscott E; Ginnivan L; Young D; Best J; ; Patterson E; Liew D; Segal L; May C; Blackberry I
    BMJ; 2017 Mar; 356():j783. PubMed ID: 28274941
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials.
    Godoi A; Reis Marques I; Padrão EMH; Mahesh A; Hespanhol LC; Riceto Loyola Júnior JE; de Souza IAF; Moreira VCS; Silva CH; Miyawaki IA; Oommen C; Gomes C; Silva AC; Advani K; de Sa JR
    Diabetol Metab Syndr; 2023 Sep; 15(1):190. PubMed ID: 37759290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cluster randomized controlled non-inferiority trial of 5-day Dose Adjustment for Normal Eating (DAFNE) training delivered over 1 week versus 5-day DAFNE training delivered over 5 weeks: the DAFNE 5 × 1-day trial.
    Elliott J; Rankin D; Jacques RM; Lawton J; Emery CJ; Campbell MJ; Dixon S; Heller SR;
    Diabet Med; 2015 Mar; 32(3):391-8. PubMed ID: 25363466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
    Pieber TR; Bode B; Mertens A; Cho YM; Christiansen E; Hertz CL; Wallenstein SOR; Buse JB;
    Lancet Diabetes Endocrinol; 2019 Jul; 7(7):528-539. PubMed ID: 31189520
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.